ONWD Share Price Performance
€4.18
-0.79 (-15.83%)
Price €4.18
Share Price€4.18
ONWD Community Narratives
There are no narratives available yet.
Recent ONWD News & Updates
No updates
Onward Medical N.V. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Sep 04, 2025
- Earnings per share (EPS)
- -0.80
- Gross Margin
- -699.60%
- Net Profit Margin
- -2,054.34%
- Debt/Equity Ratio
- 29.1%
Onward Medical N.V. Competitors
About ONWD
- Founded
- 2014
- Employees
- 103
- CEO
- WebsiteView website
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement. It operates in France, Germany, the Netherlands, the United Kingdom, and Switzerland. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Dutch Market Performance
- 7 Days: -3.2%
- 3 Months: 0.9%
- 1 Year: 1.7%
- Year to Date: 1.0%
Over the last 7 days, the market has dropped 3.2%, driven by a decline of 4.3% in the Information Technology sector. In contrast, the Energy sector has actually gained 3.0%. Overall the market has been flat in the last year. Earnings are forecast to grow by 8.7% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading